Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
LONDON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024 at 9:35 a.m. Eastern Time.
伦敦，2024年11月26日（环球新闻社）-- Kiniksa Pharmaceuticals International, plc（纳斯达克：KNSA）今天宣布管理层将于2024年12月3日东部时间上午9:35参加第七届Evercore ISI HealthCONx会议的炉边聊天。
A live webcast of Kiniksa's presentation will be accessible through the Investors section of the company's website at . A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event.
Kiniksa的演讲将通过公司网站的投资者板块进行现场直播。活动的重播将在活动结束后大约48小时内在Kiniksa的网站上提供。
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit .
关于Kiniksa
Kiniksa是一家处于商业阶段的生物制药公司，专注于发现、收购、开发和商业化治疗药物，以帮助那些面临重大医疗需求的疾病患者。Kiniksa的免疫调节资产基于强有力的生物学理论或经过验证的机制，针对一系列被忽视的心血管和自身免疫疾病，并提供差异化的潜力。欲了解更多信息，请访问。
Every Second Counts!
每一秒都很重要！
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa投资者联系
乔纳森·基尔申鲍姆
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
Kiniksa媒体联系
泰勒·加农
(781) 431-9100
tgagnon@kiniksa.com
